WealthCare Investment Partners’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.56M Buy
197,881
+23,107
+13% +$979K 2.08% 9
2026
Q1
$6.84M Buy
174,774
+114,276
+189% +$4.63M 1.9% 12
2025
Q4
$2.48M Buy
60,498
+13,112
+28% +$534K 0.72% 41
2025
Q3
$1.92M Buy
47,386
+23,608
+99% +$910K 0.62% 47
2025
Q2
$889K Buy
23,778
+3,183
+15% +$108K 0.32% 75
2025
Q1
$626K Buy
20,595
+7,012
+52% +$244K 0.27% 75
2024
Q4
$471K Buy
13,583
+1,028
+8% +$36.1K 0.21% 96
2024
Q3
$423K Buy
+12,555
New +$411K 0.19% 99

Other funds holding RECS

WealthCare Investment Partners's RECS Position: Q2 2026 in Review

WealthCare Investment Partners increased its Columbia Research Enhanced Core ETF (RECS) stake by 13% in Q2 2026, buying an estimated $979K and bringing the position to 197,881 shares worth $8.56M. The position accounts for 2.08% of the portfolio, ranked #9.

WealthCare Investment Partners first reported a position in RECS in Q3 2024 and has held it in 8 quarters since. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • WealthCare Investment Partners held 197,881 shares of Columbia Research Enhanced Core ETF worth $8.56M as of Q2 2026.
  • WealthCare Investment Partners bought 23,107 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $979K.
  • Columbia Research Enhanced Core ETF made up 2.08% of WealthCare Investment Partners's portfolio in Q2 2026, its #9 holding.
  • WealthCare Investment Partners first reported a position in Columbia Research Enhanced Core ETF in Q3 2024 and has held it in 8 quarters since.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on WealthCare Investment Partners's 13F filing for Q2 2026, filed 10 Aug 2026.